InChI=1S/C17H17F3N4.2C4H4O4/c1- 22- 7- 9- 23(10- 8- 22) 16- 15- 3- 2- 6- 24(15) 14- 5- 4- 12(17(18,19) 20) 11- 13(14) 21- 16;2*5- 3(6) 1- 2- 4(7) 8/h2- 6,11H,7- 10H2,1H3;2*1- 2H,(H,5,6) (H,7,8) /b;2*2- 1- |
HTEVMLYDEWVIQE-SPIKMXEPSA-N |
[H+] .[H+] .[H+] .[H+] .[O- ] C(=O) \C=C/C([O- ] ) =O.[O- ] C(=O) \C=C/C([O- ] ) =O.CN1CCN(CC1) c1nc2cc(ccc2n2cccc12) C(F) (F) F |
|
serotonergic agonist
An agent that has an affinity for serotonin receptors and is able to mimic the effects of serotonin by stimulating the physiologic activity at the cell receptors. Serotonin agonists are used as antidepressants, anxiolytics, and in the treatment of migraine disorders.
|
|
serotonergic agonist
An agent that has an affinity for serotonin receptors and is able to mimic the effects of serotonin by stimulating the physiologic activity at the cell receptors. Serotonin agonists are used as antidepressants, anxiolytics, and in the treatment of migraine disorders.
prodrug
A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug.
|
|
View more via ChEBI Ontology
Outgoing
|
4-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)pyrrolo[1,2-a]quinoxaline dimaleate
(CHEBI:64053)
has part
4-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)pyrrolo[1,2-a]quinoxaline
(CHEBI:64055)
4-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)pyrrolo[1,2-a]quinoxaline dimaleate
(CHEBI:64053)
has role
prodrug
(CHEBI:50266)
4-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)pyrrolo[1,2-a]quinoxaline dimaleate
(CHEBI:64053)
has role
serotonergic agonist
(CHEBI:35941)
4-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)pyrrolo[1,2-a]quinoxaline dimaleate
(CHEBI:64053)
is a
maleate salt
(CHEBI:50221)
|
|
4- (4- methylpiperazin- 1- yl)- 7- (trifluoromethyl)pyrrolo[1,2- a]quinoxaline di[(2Z)- but- 2- enedioate]
|
CGS 12066B
|
ChemIDplus
|
CGS 12066B dimaleate
|
ChEBI
|
109028-10-6
|
CAS Registry Number
|
ChemIDplus
|
|